 BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) saw a large decrease in short interest in the month of October. As of October 15th, there was short interest totaling 15,400 shares,  a decrease of 63.1% from the September 30th total of 41,700 shares. Based on an average trading volume of 1,040,000 shares, the short-interest ratio is currently 0.0 days. Currently, 1.2% of the shares of the stock are short sold. Currently, 1.2% of the shares of the stock are short sold. Based on an average trading volume of 1,040,000 shares, the short-interest ratio is currently 0.0 days.
BioNexus Gene Lab Corp. (NASDAQ:BGLC – Get Free Report) saw a large decrease in short interest in the month of October. As of October 15th, there was short interest totaling 15,400 shares,  a decrease of 63.1% from the September 30th total of 41,700 shares. Based on an average trading volume of 1,040,000 shares, the short-interest ratio is currently 0.0 days. Currently, 1.2% of the shares of the stock are short sold. Currently, 1.2% of the shares of the stock are short sold. Based on an average trading volume of 1,040,000 shares, the short-interest ratio is currently 0.0 days. 
Analysts Set New Price Targets
Separately, Weiss Ratings reaffirmed a “sell (e+)” rating on shares of BioNexus Gene Lab in a report on Thursday. One research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has a consensus rating of “Sell”.
Check Out Our Latest Report on BioNexus Gene Lab
BioNexus Gene Lab Price Performance
BioNexus Gene Lab (NASDAQ:BGLC – Get Free Report) last issued its earnings results on Monday, August 18th. The company reported ($0.34) earnings per share (EPS) for the quarter. BioNexus Gene Lab had a negative return on equity of 35.54% and a negative net margin of 30.70%.The firm had revenue of $2.26 million during the quarter.
BioNexus Gene Lab Company Profile
BioNexus Gene Lab Corp., through its subsidiary, sells chemical raw material products in Malaysia, Indonesia, Vietnam, and other countries in Southeast Asia. The company offers chemical raw material products, which include Polyester Resin SHCP 268, a thixotropic, quick-curing unsaturated polyester resin suitable as a general-purpose resin; Polyester Resin 9509, a general-purpose material used in production of marine boats and water slides; and Polyester Resin 2802 used as a component in the pultrusion process by certain manufacturers.
Recommended Stories
- Five stocks we like better than BioNexus Gene Lab
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Why Microsoft’s Post-Earnings Dip Is a Buy-the-Pause Moment
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- NVIDIA’s Billion-Dollar Bet Puts Nokia Back in the Growth Game
- What Are Some of the Best Large-Cap Stocks to Buy?
- Hold Ratings, High Rewards? 3 Stocks That Could Defy Expectations
Receive News & Ratings for BioNexus Gene Lab Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BioNexus Gene Lab and related companies with MarketBeat.com's FREE daily email newsletter.

 
						 
						 
						 
						 
						